CD4 and HIV-1 infection: The therapeutic potential of CD4+ CTL may be exploited also for vaccination purposes against HIV-1 infection, since these effectors are able to efficiently recognize and kill infected APC like macrophages, which constitute long-lived viral reservoirs (82).